Further investigation of the mechanism of Prickle2 in AD revealed that Prickle2 could inhibit the Wnt/PCP/JNK pathway in vivo and in vitro Our results suggested that Prickle2 holds potential as a promising candidate for the diagnosis and treatment of AD. This evidence concerns the gene PRICKLE2 and Alzheimer disease.